¿Cuáles son las probabilidades actuales de Does Cannabidiol (CBD) aggravate Cannabinoid Hyperemesis Syndrome (CHS) symptoms??

Manifold Markets cotiza Yes al 68.8% a fecha de 2 de noviembre de 2026.

Does Cannabidiol (CBD) aggravate Cannabinoid Hyperemesis Syndrome (CHS) symptoms?

Manifold MarketsSin KYCDatos de resolución verificadosBien calibrado

Pronóstico comunitario actual

Sí 68.8%

Pronosticadores

Tipo de pregunta

binary

Metodología

Play-money forecasting platform

Tipo de fuente

Pronóstico

Datos de mercado

Actualizado hace 1 hora

Retrasado

14 may 24, 0:51 UTC21 may 27, 4:59 UTC

Tendencias

Resultado24hProbabilidad

Reglas

Cannabinoid Hyperemesis Syndrome (CHS) is thought to be caused by an overstimulation, downregulation or both of the endocannabinoid system.

Compounds such as Tetrahydrocannabinol (THC) are thought to be the primary cause of CHS due to the way they bind to receptors.
Cannabidiol (CBD) is said to interact with the CB1 receptors in a less direct way and could have anti-nasua properties.
This market resolves Yes if studies prove CBD aggravates CHS symptoms.
Resolves No if it's proven CBD does not cause a worsening of symptoms.